Peptide Physiological Impact: How Peptides Act as Signalling Molecules

By What Peptides Editorial Team · Updated 2026-09-14 · Part of What Peptides Are: Structure, Bonds and How Chains Are Built

Peptides mostly act as messages rather than as material. A chain of two to fifty residues can be assembled, released, read and destroyed quickly, which suits communication better than it suits structure. This page describes those roles at the level of mechanism: how peptides function as hormones, neuropeptides, antimicrobial peptides and membrane-crossing motifs, and how each signal is switched off. It deliberately does not describe outcomes for a reader, because doing so would put it in medical territory that this site stays out of.

Two constraints shape everything below. Peptides are either translated directly or cut out of a larger precursor, so the same genetic information can produce several different active chains depending on where the cuts fall, and they are attacked by peptidases wherever they go, so their signals are inherently transient. That second point makes half-life the central variable. The identical sequence behaves differently when it is released from a stored precursor, when it circulates freely, or when it carries a chemical modification that blocks an exopeptidase. The structural basis for all of this sits in the peptide chemistry and structure reference.

Nothing here is advice, and none of these categories should be read as a suggestion to use anything. Read this as descriptive biology: what such molecules are observed to do, and what stops them doing it.

Hormones and Neuropeptides as Messages

Peptide hormones are secreted from a cell, travel through extracellular fluid or blood, and are read by a receptor on a target cell. Insulin is the standard example: 51 residues arranged in two chains joined by disulfide bridges, stored in secretory granules as a zinc-associated hexamer, and released as the processed two-chain form. Circulating chains of this size do not cross cell membranes by diffusion. They bind receptors whose intracellular side carries out the rest, so the peptide itself is the address and the trigger rather than the machinery.

Neuropeptides work on a shorter range and a faster schedule. Substance P is an 11-residue chain released at synapses, where it acts on G protein-coupled receptors and produces slower, longer-lived modulation than the small-molecule transmitters released alongside it. Most such peptides are produced by processing rather than by direct translation. A preproprotein carries an N-terminal secretory signal sequence that is removed during translocation into the endoplasmic reticulum; the remaining proprotein is then cut at paired basic residues by prohormone convertases, trimmed by carboxypeptidase, and frequently amidated at the new C-terminus. Many peptide hormones end in an amide for exactly this reason.

Small differences carry disproportionate weight here. Oxytocin and vasopressin are each nine residues with a disulfide bridge forming a six-residue ring plus a three-residue tail, and they differ at two positions, yet they act on separate receptors with separate roles. That sensitivity is why the same processing pathway can yield several distinct signals from one precursor, and it is also why a single-residue substitution in a synthetic analogue can change receptor preference entirely. The a short basic motif acting as an address tag is another example of information carried by a very short stretch of residues.

Antimicrobial Peptides and Membrane-Active Motifs

Antimicrobial peptides are a large, old group found across animals, plants and fungi, where they form part of innate defence. They are typically short, cationic and amphiphilic: the sequence arranges so that cationic and nonpolar residues occupy opposite faces of a helix once it forms. That organisation lets them associate with bacterial surfaces, which carry more anionic lipid in their outer leaflet than typical animal cell surfaces do, and then insert into the membrane. Models describe the outcome in terms of carpet coverage, toroidal pores or barrel-stave assemblies, depending on the peptide and the lipid composition.

Cell-penetrating peptides exploit related physics with a different goal. Sequences rich in arginine and lysine, such as the well-known segment from the HIV-1 Tat protein spanning residues 48 to 60, associate with negatively charged membrane components and are internalised, carrying attached cargo with them. Efficiency depends heavily on what is attached and how much of it there is, and a large fraction of internalised material remains trapped in endosomes rather than reaching the cytosol. The design principle is spelled out in how residue placement puts each property on a different face.

Half-Life, Degradation and Modification

Peptides are removed by three broad routes, and all three run at once. Exopeptidases trim from the ends; aminopeptidases attack the N-terminus and carboxypeptidases the C-terminus. Endopeptidases cut internally at favoured residues, with dipeptidyl peptidase-4 being the textbook case because it removes an N-terminal dipeptide whenever the second residue is alanine or proline, which is why glucagon-like peptide-1 fragments are short-lived in plasma. Finally, small chains are cleared by the kidney: peptides small enough to pass the glomerular filter are lost into urine on a timescale of minutes unless they are bound to something larger.

Chemical modification is the standard answer used in research and in drug design, and each change attacks one specific weak point. Amidation of the C-terminus and acetylation of the N-terminus remove the charges that exopeptidases recognise. Substituting a D-amino acid at a cleavage site stops an endopeptidase that cannot accommodate the mirror-image geometry. Cyclisation, either by a disulfide bridge or head-to-tail, removes both termini at once. Conjugation to a large carrier such as an albumin-binding motif, an antibody fragment or a polyethylene glycol chain pushes the construct above the filtration threshold. These are design strategies observed in the literature, not recommendations.

The practical consequence for anyone handling peptides is that stability is a property of both sequence and environment. Lyophilised powder stored cold and dry behaves very differently from a dilute solution left at room temperature in a plastic tube, and repeated freeze-thaw cycles are the usual failure mode. Storage conventions are collected in what is usually done with lyophilised powder and reconstituted solution, and the fine detail of where chains get cut is covered in how tryptic cleavage defines predictable fragments. Whether any of these strategies apply to a given sequence is a question for the laboratory doing the work, not for an educational page.

This page is part of the What Peptides Are: Structure, Bonds and How Chains Are Built guide.